Return to program book search
Treating Tumors and Inflammatory Skin Diseases with Immunomodulators and Biologics
Friday, March 21
10:00 AM - 12:00 PM
Neal D. Bhatia, MD, FAAD
- Andrew Blauvelt, MD, FAAD
- James Q. Del Rosso, DO
- Adam J. Friedman, MD, FAAD
- Theodore Rosen, MD, FAAD
Following this course, the attendee should be able to:
- Categorize and differentiate dermatoses based on their inflammatory versus neoplastic origin and their potential responses to topical and systemic immunotherapies.
- Recognize potential applications of immune-based therapies outside of conventional uses.
- Select therapeutic options to modify a disease process in addition to alleviate symptoms based on the immune mechanisms that create them.
As the understanding of immune system pathways, cytokine balances, and cellular interactions continues to expand, so must the potential applications of immune-based therapies. Our current therapeutic regimens are only as efficacious as our comfort with their utilities, which can only begin with matching which immune processes can be countered and modified by which therapies. The goals of this session are to review some of the principles of immunodermatology, to explain and dissect various immune system functions and dysfunctions that create inflammatory dermatoses as well as promote tumor proliferation, and to explore potential applications of conventional topical and systemic therapies to impact those diseases.
|Friday, March 21|
|10:00 AM||Introduction / |
|10:01 AM||Topical Immunomodulators/Anti-inflammatoryagents / Dr. Del Rosso|
|10:30 AM||Nanotechnology and Immunomodulators / Dr. Friedman|
|11:00 AM||Biologics as Immunomodulators / Dr. Blauvelt|
|11:30 AM||Antibiotics as Immunomodulators / Dr. Rosen|
|11:45 AM||Systemic immunomodulators / Dr. Bhatia|